A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

Most new cell therapies work well on blood cancers but not on solid tumors like pancreatic cancer. Pancreatic tumors are ...

Garsorasib shrank tumours in nearly half of patients with KRAS G12C pancreatic cancer and showed manageable side effects.

Telemedicine is delivering hope to the homes of pancreatic cancer patients through a first-of-its-kind clinical trial.

UCLA’s CAR-NKT therapy overcomes solid-tumor barriers, eliminating primary and metastatic pancreatic cancer in advanced ...

Scientists have created a new antibody treatment that helps the immune system recognize and attack pancreatic cancer. Pancreatic cancer cells use a sugary "disguise" to trick the immune system into ...

DelveInsight's Pancreatic Cancer Market Insights report includes a comprehensive understanding of current treatment practices, ...

Early diagnosis, personalised therapies and new targeted drugs are marking a paradigm shift for one of the cancers with the ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. With an overall survival rate of around 13%, it’s also one of the deadliest cancers. One reason for this is that ...

Treating pancreatic cancer remains one of oncology’s greatest challenges. The disease is often diagnosed at an advanced stage, progresses rapidly, and responds poorly to existing treatments.